Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Affibody, Apellis, Ashvattha, Bausch, Bioinvent, Bioxcel, Compass, Curium, Horizon, Hoth, Imago, Karolinska, Kymera, Mustang, Nanology, Oramed, Polarityte, Remynd, Saol, UCB, Umoja, Xenon, Xortx.